Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Receptor Blockers ◽

Tripterygium Glycosides

PDB24 A PHARMACOECONOMIC COMPARISON BETWEEN ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH DIABETIC NEPHROPATHY

Value in Health ◽

10.1016/s1098-3015(10)64972-8 ◽

2007 ◽

Vol 10 (6) ◽

pp. A261

Author(s):

P Stafylas ◽

P Sarafidis ◽

V Aletras

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison

Journal of the Renin-Angiotensin-Aldosterone System ◽

10.1177/1470320309352352 ◽

2009 ◽

Vol 10 (4) ◽

pp. 195-200 ◽

Cited By ~ 4

Author(s):

Nicolás Roberto Robles ◽

Baldomero Romero ◽

Enrique Fernandez-Carbonero ◽

Emilio Sánchez-Casado ◽

Juan Jose Cubero

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Retrospective Comparison ◽

Reviewing the benefits of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in diabetic nephropathy – are they drug specific or class specific?

Canadian Journal of Cardiology ◽

10.1016/s0828-282x(10)71169-7 ◽

2010 ◽

Vol 26 ◽

pp. 15E-19E ◽

Cited By ~ 3

Author(s):

Ellen Burgess

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy

Indian Journal of Pharmacology ◽

10.4103/0253-7613.153420 ◽

2015 ◽

Vol 47 (2) ◽

pp. 148 ◽

Cited By ~ 6

Author(s):

JahnaviV Pathak ◽

ErvillaE Dass

Keyword(s):

Diabetic Nephropathy ◽

Retrospective Study ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Faculty Opinions recommendation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726264595.793522878 ◽

2016 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Renal Dysfunction ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

Cancer Epidemiology ◽

10.1016/j.canep.2009.10.005 ◽

2009 ◽

Vol 33 (5) ◽

pp. 391-395 ◽

Cited By ~ 14

Author(s):

E.R. Koomen ◽

R.M.C. Herings ◽

H.J. Guchelaar ◽

T. Nijsten

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Melanoma Incidence ◽

Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study

Journal of Clinical Hypertension ◽

10.1111/j.1751-7176.2012.00687.x ◽

2012 ◽

Vol 14 (10) ◽

pp. 731-731 ◽

Cited By ~ 1

Author(s):

John J.V. McMurray ◽

Robert M. Califf ◽

Angelyn M. Bethel ◽

Steven M. Haffner ◽

Rury R. Holman

Keyword(s):

Cohort Study ◽

Comparative Effectiveness ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

American Heart Journal ◽

10.1016/j.ahj.2004.04.037 ◽

2004 ◽

Vol 148 (5) ◽

pp. 747-754 ◽

Cited By ~ 47

Author(s):

Sverre E. Kjeldsen ◽

Stevo Julius

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

End Points ◽

Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. A Meta-Analysis

ACC Current Journal Review ◽

10.1016/j.accreview.2005.08.243 ◽

2005 ◽

Vol 14 (9) ◽

pp. 49-50 ◽

Cited By ~ 5

Author(s):

J.S. Healey ◽

A. Baranchuk ◽

E. Crystal

Keyword(s):

Atrial Fibrillation ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Nephron ◽

10.1159/000447068 ◽

2016 ◽

Vol 133 (3) ◽

pp. 147-158 ◽

Cited By ~ 19

Author(s):

Aimun Ahmed ◽

Tom Jorna ◽

Sunil Bhandari

Keyword(s):

Kidney Disease ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽